540 likes | 2.8k Vues
Meningitis. By: Sahar Bannani ID Intern. Practical Guidelines for the Management of Bacterial Meningitis. Developed By: Infectious Diseases Society of America Date Released: November 2004 Date Modified: March 2008. Guideline Category:. Diagnosis Evaluation Management Treatment.
E N D
Meningitis By: SaharBannani ID Intern
Practical Guidelines for the Management of Bacterial Meningitis • Developed By:Infectious Diseases Society of America • Date Released:November 2004 • Date Modified:March 2008
Guideline Category: • Diagnosis • Evaluation • Management • Treatment
Rating Scheme • Strength of Evidence:I, II, III • Strength of the Recommendations:A, B, C, D, E
Diagnosis • Hx and P/Ex • Blood Cultures • LP • Serum Procalcitonin • CT • LP: • WBCs, RBCs, Bacteria, Proteins, Glucose • Lactate • CRP • Gram Stain • Latex Agglutination Test • Limulus Lysate Assay • PCR / RT-PCR
Which Patients with Suspected Bacterial Meningitis Should Undergo CT before LP?
B-II • Immunocompromised State • Hx of CNS Disease • New Onset Seizure • Papilledema • Abnormal Level of Consciousness • Focal Neurological Deficit
What Specific CSF Diagnostic Tests Should Be Used to Determine the Bacterial Etiology of Meningitis?
Gram Stain (A-III) • Latex Agglutination (D-II) • G-Stain –ve (C-II) • Pretreated (B-III) • Limulus Lysate Assay (D-II) • PCR (B-II)
What Lab Tests Helps in Distinguishing Bacterial from Viral Meningitis?
Bacterial vs. Viral • Lactate Concerntration (D-III) • Post-op NeuroSurg (B-II) • CRP (B-II) • Procalcitonin (C-II) • PCR (B-II)
How Quickly Should Antimicrobial Therapy be Administered in Suspected Bacterial Meningitis? C-III
Specific Antimicrobial Therapy (A-111) • Child + suspected L. Monocytogenes: Ampi + 3G Ceph + Vanco • Child + Suspected G-ve enteric bacteria: Ampi + Aminoglycoside
Duration of Antimicrobial Therapy(A-III) • N. meningitidis, H. influenza 7 days • S. pneumoniae 10 – 14 days • S. agalactiae 14 – 21 days • Aerobic G-ve Bacilli, L. monocytogenes 21 days
Role of Dexa • Neonates (C-I) • Infants and Children: • H. influenza b (A-I) • Post Antimicrobial Rx (A-I) • Pneumococcal (C-I) • Adults: • Pneumococcal (A-I) • Post Antimicrobial Rx (A-I) • All (B-III) • Pneumococcal Meningitis (B-III) • Rifampin + Vanco + 3G Ceph + Dexa (B-III)
Specific Antimicrobial Therapy • Cephalosporins • Vancomycin • Rifampin • Carbapenems • Flouroquinolones
Bacterial Meningitis postCSF-Shunting • Do we administer Antimicrobial Therapy by Intraventricular Route?(A-III) vs. (B-III)
Bacterial Meningitis fromPre-Existing CSF-Shunt • Do we remove the shunt? And when a new one can be implanted? (A-II) (B-II) (C-III)
Indications for Repeated LP (A-III)
Criteria for Out-Patient Rx(A-III) • In-patient Rx ≥ 6 days • Afebrile 24-48 hrs • No neuro dysfunction • Stable • PO intake • Access to home nursing for Rx • Reliable IVL and infusion device (if needed) • Daily availability of a physician • Plan • Compliance • Safe environment
Management Algorithm for Children with Suspected Bacterial Meningitis
Management Algorithm for Adults with Suspected Bacterial Meningitis